Cargando…

Inhaled corticosteroids, blood eosinophils, and FEV(1) decline in patients with COPD in a large UK primary health care setting

Background: Inhaled corticosteroid (ICS)-containing medications slow rate of decline of FEV(1). Blood eosinophil (EOS) levels are associated with the degree of exacerbation reduction with ICS. Purpose: We investigated whether FEV(1) decline differs between patients with and without ICS, stratified b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whittaker, Hannah R, Müllerova, Hana, Jarvis, Deborah, Barnes, Neil C, Jones, Paul W, Compton, Chris H, Kiddle, Steven J, Quint, Jennifer K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536812/ https://www.ncbi.nlm.nih.gov/pubmed/31213788 http://dx.doi.org/10.2147/COPD.S200919

Ejemplares similares

Inhaled corticosteroids and FEV(1) decline in chronic obstructive pulmonary disease: a systematic review
por: Whittaker, Hannah R., et al.
Publicado: (2019)

Accelerated FEV(1) decline and risk of cardiovascular disease and mortality in a primary care population of COPD patients
por: Whittaker, Hannah R., et al.
Publicado: (2021)

Challenges and Pitfalls of Using Repeat Spirometry Recordings in Routine Primary Care Data to Measure FEV(1) Decline in a COPD Population
por: Whittaker, Hannah R, et al.
Publicado: (2021)

Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids
por: Siddiqui, Salman H, et al.
Publicado: (2018)

Rational use of inhaled corticosteroids for the treatment of COPD
por: Quint, Jennifer K., et al.
Publicado: (2023)

Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD
por: Pavord, Ian D, et al.
Publicado: (2016)

Characteristics Associated with Accelerated Lung Function Decline in a Primary Care Population with Chronic Obstructive Pulmonary Disease
por: Whittaker, Hannah R, et al.
Publicado: (2020)

Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study
por: Bloom, Chloe I, et al.
Publicado: (2020)

Frequency and severity of respiratory infections prior to COPD diagnosis and risk of subsequent postdiagnosis COPD exacerbations and mortality: EXACOS-UK health care data study
por: Whittaker, Hannah, et al.
Publicado: (2023)

Frequency and Severity of Exacerbations of COPD Associated with Future Risk of Exacerbations and Mortality: A UK Routine Health Care Data Study
por: Whittaker, Hannah, et al.
Publicado: (2022)

Association of blood eosinophils and plasma periostin with FEV(1) response after 3-month inhaled corticosteroid and long-acting beta(2)-agonist treatment in stable COPD patients
por: Park, Hye Yun, et al.
Publicado: (2015)

Effect of inhaled corticosteroids on blood eosinophil count in steroid-naïve patients with COPD
por: Kreindler, James L, et al.
Publicado: (2016)

Blood eosinophils and inhaled corticosteroids in patients with COPD: systematic review and meta-analysis
por: Cheng, Shih-Lung
Publicado: (2018)

Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019)

Validity and interpretation of spirometric recordings to diagnose COPD in UK primary care
por: Rothnie, Kieran J, et al.
Publicado: (2017)

The Association Between Eosinophil Variability Patterns and the Efficacy of Inhaled Corticosteroids in Stable COPD Patients
por: Yoon, Jung-Ki, et al.
Publicado: (2020)

Bronchiectasis-COPD Overlap Syndrome: Role of Peripheral Eosinophil Count and Inhaled Corticosteroid Treatment
por: Oscullo, Grace, et al.
Publicado: (2023)

Prediction of five-year mortality after COPD diagnosis using primary care records
por: Kiddle, Steven J., et al.
Publicado: (2020)

Risk factors for FEV(1) decline in mild COPD and high-risk populations
por: Chen, Shujing, et al.
Publicado: (2017)

Concomitant diagnosis of asthma and COPD: a quantitative study in UK primary care
por: Nissen, Francis, et al.
Publicado: (2018)

COPD management costs according to the frequency of COPD exacerbations in UK primary care
por: Punekar, Yogesh Suresh, et al.
Publicado: (2014)

Effectiveness using higher inhaled corticosteroid dosage in patients with COPD by different blood eosinophilic counts
por: Cheng, Shih-Lung, et al.
Publicado: (2016)

FEV(1) decline in relation to blood eosinophils and neutrophils in a population-based asthma cohort
por: Backman, Helena, et al.
Publicado: (2020)

Asthma and treatment with inhaled corticosteroids: associations with hospitalisations with pneumonia
por: Ekbom, Emil, et al.
Publicado: (2019)

Inhaled Corticosteroids and the Lung Microbiome in COPD
por: Keir, Holly R., et al.
Publicado: (2021)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Clinical burden of illness among patients with severe eosinophilic COPD
por: Müllerová, Hana, et al.
Publicado: (2019)

Validation of the Recording of Acute Exacerbations of COPD in UK Primary Care Electronic Healthcare Records
por: Rothnie, Kieran J., et al.
Publicado: (2016)

Recording of hospitalizations for acute exacerbations of COPD in UK electronic health care records
por: Rothnie, Kieran J, et al.
Publicado: (2016)

Lower FEV(1) in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV(1), total IgE levels, and TSLP genotypes
por: Masuko, Hironori, et al.
Publicado: (2011)

Inhaled corticosteroid effects both eosinophilic and non-eosinophilic inflammation in asthmatic patients.
por: Basyigit, Ilknur, et al.
Publicado: (2004)

Inhaled Corticosteroids
por: Barnes, Peter J.
Publicado: (2010)

Inhaled corticosteroids in COPD and the risk of serious pneumonia
por: Suissa, Samy, et al.
Publicado: (2013)

Inhaled corticosteroids in COPD: Personalising the therapeutic choice
por: Shaw, J A, et al.
Publicado: (2018)

How inhaled corticosteroids target inflammation in COPD
por: Lea, Simon, et al.
Publicado: (2023)

Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy
por: Benson, Victoria S, et al.
Publicado: (2019)

Inhaled Corticosteroid Treatment Regimens and Health Outcomes in a UK COPD Population Study [Corrigendum]
Publicado: (2020)

COPD sputum eosinophils: relationship to blood eosinophils and the effect of inhaled PDE4 inhibition
por: Singh, Dave, et al.
Publicado: (2020)

Exacerbations and health care resource use among patients with COPD in relation to blood eosinophil counts
por: Müllerová, Hana, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_iq54lmk25o2q3cvd1r2em4ku10